The global meningococcal vaccine market size was USD 3.10 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Increasing prevalence of meningitis and rising investment in new vaccine development are key factors driving the market revenue growth. Additionally, technological advancement in the field is another factor contributing to market revenue...
Deutsch 
English
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
urdu